Abstract
Levels of CXCL13, a potent B-cell chemoattractant, are elevated in the cerebrospinal fluid (CSF) during multiple sclerosis (MS) and are associated with markers of MS activity. Levels decrease upon effective treatments.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Multiple Sclerosis |
| Vol/bind | 17 |
| Udgave nummer | 3 |
| Sider (fra-til) | 335-43 |
| Antal sider | 9 |
| ISSN | 1352-4585 |
| DOI | |
| Status | Udgivet - 2011 |
Fingeraftryk
Dyk ned i forskningsemnerne om 'Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS